Trial intelligence / Profile preview

Hydration Dynamics and Beverage Composition

NCT05111392Phase 2Completed

Sponsor
University of Illinois Chicago
Start
Sep 2021
Primary completion
Oct 2022
Countries
1
01

Overview

Phase 2, randomised, single-blind trial (3 arms), sponsored by University of Illinois Chicago. Primary endpoint: Rate of appearance of deuterium in the plasma at 2 hours. Started Sep 2021; status: completed.

Beyond the preview

Go deeper on NCT05111392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05111392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call